These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8096668)

  • 21. A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia.
    Suzuki H; Gen K; Takahashi Y
    Hum Psychopharmacol; 2014 Jan; 29(1):83-8. PubMed ID: 24424709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. R-R interval during neuroleptic treatment.
    Motomura N; Asaba H; Sakai T
    Biol Psychiatry; 1989 Jun; 26(2):219-20. PubMed ID: 2567613
    [No Abstract]   [Full Text] [Related]  

  • 23. Relation of graded ocular anterior chamber pigmentation to phenothiazine intake in schizophrenics--quantification procedures.
    Thaler JS; Curinga R; Kiracofe G
    Am J Optom Physiol Opt; 1985 Sep; 62(9):600-4. PubMed ID: 4050962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of extrapyramidal manifestations induced by neuroleptics].
    Bordeleau JM; Tétreault L
    Rev Can Biol; 1972; 31():Suppl:247-53. PubMed ID: 4403291
    [No Abstract]   [Full Text] [Related]  

  • 25. [The neuroleptic substances and the behavior of insects. III. Influence on the post-embryonic development of Tribolium confusum Duval (Coleoptera: Tenebrionidae)].
    HUOT L; CORRIVAULT GW; LEBLANC J
    Arch Int Physiol Biochim; 1963 Mar; 71():215-23. PubMed ID: 13955808
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution.
    Kornhuber J; Wiltfang J; Riederer P; Bleich S
    Eur Arch Psychiatry Clin Neurosci; 2006 Aug; 256(5):274-80. PubMed ID: 16788768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative symptoms and neuroleptics in catatonic schizophrenia.
    Salokangas RK; Honkonen T; Stengård E; Koivisto AM; Hietala J
    Schizophr Res; 2003 Jan; 59(1):73-6. PubMed ID: 12413645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [LATENT NEURO-VEGETATIVE DISORDERS DURING CURES WITH NEUROLEPTICS. INCIDENTS AND ACCIDENTS IN CHILDREN AND ADOLESCENTS].
    GAYRAL L; ROUX G; TURNIN J
    Encephale; 1964; 53():SUPPL:175-9. PubMed ID: 14161530
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical evaluation of pipotiazine palmitate (19.552 R.P.) used on patients in an acute reception ward.
    Elley JH; Petersen JH
    Acta Psychiatr Scand Suppl; 1973; 241():75-82. PubMed ID: 4147514
    [No Abstract]   [Full Text] [Related]  

  • 30. Schizophrenia and the pineal gland.
    Greiner AC
    Can Psychiatr Assoc J; 1970 Oct; 15(5):433-47. PubMed ID: 5492186
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia.
    Krausz M; Moritz S; Lambert M; Naber D
    Int Clin Psychopharmacol; 2000 Mar; 15(2):77-81. PubMed ID: 10759338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo study of the mutagenicity of biperidine, pipotiazine, chlorpromazine, and haloperidol.
    Smith M; de Souza MA; Pugliese S; Mari Jde J
    Am J Med Genet; 1996 Apr; 67(2):238. PubMed ID: 8723058
    [No Abstract]   [Full Text] [Related]  

  • 34. Low serum neuroleptic levels predict relapse in schizophrenic patients.
    Brown WA; Laughren T; Chisholm E; Williams BW
    Arch Gen Psychiatry; 1982 Sep; 39(9):998-1000. PubMed ID: 6126172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phototoxic properties of neuroleptic drugs.
    Eberlein-König B; Bindl A; Przybilla B
    Dermatology; 1997; 194(2):131-5. PubMed ID: 9094460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients.
    Hershey LA; Gift T; Atkins RW; Rivera-Calimlim L
    Psychopharmacology (Berl); 1981; 73(4):355-8. PubMed ID: 6789357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levomepromazine for schizophrenia.
    Sivaraman P; Rattehalli R; Jayaram M
    Schizophr Bull; 2012 Mar; 38(2):219-20. PubMed ID: 22114097
    [No Abstract]   [Full Text] [Related]  

  • 38. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.
    Moritz S; Krausz M; Gottwalz E; Andresen B
    Compr Psychiatry; 2000; 41(4):284-8. PubMed ID: 10929797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot trials with long-acting pipotiazine injections.
    Hakola A
    Acta Psychiatr Scand Suppl; 1973; 241():31-42. PubMed ID: 4147509
    [No Abstract]   [Full Text] [Related]  

  • 40. [A differential effect profile of neuroleptic therapy of acute schizophrenic patients? Results of a clinico-naturalistic study].
    Schmidt LG; Siemetzki H
    Nervenarzt; 1988 Dec; 59(12):721-6. PubMed ID: 2905770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.